| Identification | Back Directory | [Name]
SEP-0372814 | [CAS]
1516895-53-6 | [Synonyms]
CS-1706
PDE10-IN-2
SEP-0372814
SEP 0372814;SEP0372814
5,8-dimethyl-2-[(1R,2R)-2-{3-methylimidazo[2,1-f]1,6-naphthyridin-2-yl}cyclopropyl]-[1,2,4]triazolo[1,5-a]pyrazine
rel-2-[(1R,2R)-2-(5,8-Dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methylimidazo[2,1-f][1,6]naphthyridine
Imidazo[2,1-f][1,6]naphthyridine, 2-[(1R,2R)-2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methyl-, rel- | [Molecular Formula]
C21H19N7 | [MOL File]
1516895-53-6.mol | [Molecular Weight]
369.42 |
| Chemical Properties | Back Directory | [density ]
1.52±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
Chloroform: slightly soluble; DMF: slightly soluble; Methanol: 1 mg/ml | [form ]
A crystalline solid | [pka]
5.38±0.50(Predicted) |
| Hazard Information | Back Directory | [Uses]
PDE10-IN-2 is a PDE10 inhibitor with an IC50≦0.01 μM[1]. | [storage]
Store at -20°C | [References]
[1] John Emmerson CAMPBELL, et al. Heteroaryl compounds and methods of use thereof. Patent US20150322090A1. |
|
|